Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences MetaboMeeting 2015

Michael Wakelam's Biography

Michael Wakelam, Professor, Babraham Institute

Professor Michael Wakelam is the Director of the Babraham Institute, an independent charitable life sciences institute, sponsored by the Biotechnology and Biological Sciences Research Council. It undertakes world-leading innovative research and advanced training with relevance to the biomedical, biotechnological, pharmaceutical and healthcare communities. The commercialisation of the Institute's research is managed by its wholly-owned trading subsidiary, Babraham Bioscience Technologies Ltd.

Professor Wakelam trained initially in medical biochemistry and biochemistry at the University of Birmingham. He has over twenty years research experience in the area of cell signalling; focusing particularly in recent years on the regulation of signalling pathways in normal and cancer cells and in inflammatory responses, and on interactions between different molecules in the pathways. The principal aim of his current research is to understand how and where in cells, signalling phosphatidic acid is produced, and to identify the molecular targets and the cellular processes regulated by phosphatidic acid.

Michael Wakelam Image

Metabolic and Signalling Changes in Cancer Determined through Lipidomics

Wednesday, 9 December 2015 at 16:00

Add to Calendar ▼2015-12-09 16:00:002015-12-09 17:00:00Europe/LondonMetabolic and Signalling Changes in Cancer Determined through LipidomicsMetaboMeeting 2015 in Cambridge, UKCambridge,

Analysis of lipid molecular species by LC-MS in cancer tissues and cell lines has defined pathways that change and has highlighted significant changes in acyl chain length and saturation that point to changes in membrane structure and highlight changes in enzyme activities that have the potential to be novel therapeutic targets.

Add to Calendar ▼2015-12-07 00:00:002015-12-09 00:00:00Europe/LondonMetaboMeeting 2015MetaboMeeting 2015 in Cambridge, UKCambridge,